Argentine government proposes regulatory changes to pharmaceutical patenting framework

The Argentine government is initiating a review of national patenting rules, potentially impacting the intellectual property landscape for pharmaceutical companies and academic research institutions. The specific scope of these regulatory adjustments remains uncertain, leaving the extent of the impact on drug pricing and innovation cycles to be determined.